Critical Pharmaceuticals and the University of Nottingham have announced a new partnership for development of a "nano-enabled" intranasal formulation of teriparatide for the treatment of osteoporosis. Funding for the £545,000 collaboration is coming from the Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC). “We are … [Read more...] about Critical Pharmaceuticals and U. of Nottingham team on osteoporosis nasal spray
Business
Acorda acquires Neuronex, diazepam nasal spray program
US pharmaceutical company Acorda Therapeutics President and CEO Ron Cohen has announced that the company is "excited" about an agreement with Neuronex, Inc. that will allow Acorda to acquire the company and its diazepam nasal spray program. Acorda has made an upfront payment of $2 million to acquire Neuronex, a North Carolina-based pharmaceutical company, plus … [Read more...] about Acorda acquires Neuronex, diazepam nasal spray program
Mylan says it will challenge verdict in Sunovion Xopenex patent infringement suit
A jury has awarded $18 million to Sunovion Pharmaceuticals after finding that Mylan willfully infringed on patents for Xopenex levalbuterol hydrochloride inhalation solution when its subsidiary Dey marketed generic versions of the product. The trial took place in the US District Court for the District of Delaware. The patents involved are US patents numbers … [Read more...] about Mylan says it will challenge verdict in Sunovion Xopenex patent infringement suit
Report estimates 6.2% increase in nebulizer sales over 5-year period
A new report from IbisWorld foresees a positive outlook for nebulizer sales after estimated annualized growth rate of 6.2% from 2007 to 2012. The report suggests that an aging population and increasing diagnoses of respiratory illnesses, plus an improving economy will help manufacturers to overcome "some market saturation and new federal regulations." Total revenue … [Read more...] about Report estimates 6.2% increase in nebulizer sales over 5-year period
GSK tests Rotacaps inhaler versus Diskus for Advair
As GSK announced its 2011 results, which included sales declines for Advair (Seretide) in the US and Europe, and after the announcement that it plans to file a marketing application for its Relovair fluticasone furoate/vilanterol DPI despite disappointing data, Bloomberg took note of GSK's recent study of a cheaper capsule-based inhaler for delivery of Advair … [Read more...] about GSK tests Rotacaps inhaler versus Diskus for Advair
Akela gets funding for its PharmaForm subsidiary
Akela Pharma has announced completion of a private placement totaling $2,310,000 that it will use primarily for expansion of spray drying and hot melt extrusion capabilities at its subsidiary, PharmaForm. Although PharmaForm specializes in solid dosage forms, it also offers services for nasal sprays and dry powder formulation development. The parent company, … [Read more...] about Akela gets funding for its PharmaForm subsidiary
Team Consulting opens new respiratory physics laboratory
Team Consulting has announced the opening of its new Respiratory Physics Laboratory at the company headquarters in Ickleton, Cambridgeshire, UK. Recent hire Mark Shepherd will manage the cGMP laboratory. “In recent years we have worked for six of the world’s top ten pharma companies and for them it is important to see us making this investment in facilities and … [Read more...] about Team Consulting opens new respiratory physics laboratory
New inhalation consortium formed in Scandinavia
The new Medicon Valley Inhalation Consortium (MVIC) includes seven inhalation technology companies located in the Skåne-Copenhagen region of Scandinavia. According to the consortium, it "will work to globally promote Medicon Valley as an international center of inhalation competence and offer a comprehensive set of world class services." Many of the member … [Read more...] about New inhalation consortium formed in Scandinavia
Recall of acetylcysteine inhalation solution
Bedford Laboratories has announced a national (US) voluntary product recall of acetylcysteine solution manufactured for Roxane Laboratories. The recall was initiated on December 20, 2011 due to a visible glass particle in a vial of solution from lot 1877093. According to the company, no adverse events have been reported. The company warned that "Use of an inhaled … [Read more...] about Recall of acetylcysteine inhalation solution
Impax acquires rights to Zomig nasal spray
California-based Impax Pharmaceuticals has acquired exclusive US rights to several dosage forms of Zomig zolmitriptan, including the nasal spray formulation, from AstraZeneca. Zomig nasal spray is approved in the US for the treatment of migraine headaches. The agreement also gives Impax non-exclusive rights to develop and commercialize new zolmitriptan products. … [Read more...] about Impax acquires rights to Zomig nasal spray